Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9,295 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment of pediatric lymphoma in Japan: Current status and plans for the future.
Kobayashi R, Sunami S, Mitsui T, Nakazawa A, Koga Y, Mori T, Tanaka F, Ueyama J, Osumi T, Fukano R, Ohki K, Sekimizu M, Mori T; Lymphoma Committee; Japanese Pediatric Leukemia/Lymphoma Study Group. Kobayashi R, et al. Among authors: mori t. Pediatr Int. 2015 Aug;57(4):523-34. doi: 10.1111/ped.12725. Pediatr Int. 2015. PMID: 26096060 Review.
Pediatric follicular lymphoma in Japan.
Kobayashi R, Tanaka F, Nakazawa A, Ueyama JI, Sunami S, Mitsui T, Koga Y, Mori T, Osumi T, Fukano R, Ohki K, Sekimizu M, Fujita N, Kamei M, Mori T; Lymphoma Committee and Japanese Pediatric Leukemia/Lymphoma Study Group. Kobayashi R, et al. Among authors: mori t. Int J Hematol. 2017 Jun;105(6):849-853. doi: 10.1007/s12185-017-2209-1. Epub 2017 Mar 7. Int J Hematol. 2017. PMID: 28271414
Clinical Features and Prognosis According to Immunophenotypic Subtypes Including the Early T-Cell Precursor Subtype of T-Lymphoblastic Lymphoma in the Japanese Pediatric Leukemia/Lymphoma Study Group ALB-NHL03 Study.
Fukano R, Sunami S, Sekimizu M, Takimoto T, Mori T, Mitsui T, Mori T, Saito AM, Watanabe T, Ohshima K, Fujimoto J, Nakazawa A, Kiyokawa N, Kobayashi R, Horibe K, Tsurusawa M. Fukano R, et al. Among authors: mori t. J Pediatr Hematol Oncol. 2018 Jan;40(1):e34-e37. doi: 10.1097/MPH.0000000000000850. J Pediatr Hematol Oncol. 2018. PMID: 28538509
Low Incidence of Osteonecrosis in Childhood Acute Lymphoblastic Leukemia Treated With ALL-97 and ALL-02 Study of Japan Association of Childhood Leukemia Study Group.
Sakamoto K, Imamura T, Kihira K, Suzuki K, Ishida H, Morita H, Kanno M, Mori T, Hiramatsu H, Matsubara K, Terui K, Takahashi Y, Suenobu SI, Hasegawa D, Kosaka Y, Kato K, Moriya-Saito A, Sato A, Kawasaki H, Yumura-Yagi K, Hara J, Hori H, Horibe K. Sakamoto K, et al. Among authors: mori t. J Clin Oncol. 2018 Mar 20;36(9):900-907. doi: 10.1200/JCO.2017.75.5066. Epub 2018 Jan 23. J Clin Oncol. 2018. PMID: 29360413
The Effect of Interim FDG-PET-guided Response-Adapted Therapy in Pediatric Patients with Hodgkin's Lymphoma (HL-14) : Protocol for a Phase II Study.
Koga Y, Baba S, Fukano R, Nakamura K, Soejima T, Maeda N, Sunami S, Ueyama J, Mitsui T, Mori T, Osumi T, Sekimizu M, Ohki K, Tanaka F, Kamei M, Fujita N, Mori T, Saito AM, Kada A, Kobayashi R. Koga Y, et al. Among authors: mori t. Acta Med Okayama. 2018 Aug;72(4):437-440. doi: 10.18926/AMO/56185. Acta Med Okayama. 2018. PMID: 30140095 Free article.
A Multicenter, Open-label, Clinical Trial to Assess the Effectiveness and Safety of Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced-intensity Conditioning in Relapsed/refractory Anaplastic Large-cell Lymphoma in Children.
Kada A, Fukano R, Mori T, Kamei M, Tanaka F, Ueyama J, Sekimizu M, Osumi T, Mori T, Koga Y, Ohki K, Fujita N, Mitsui T, Saito AM, Hashimoto H, Kobayashi R. Kada A, et al. Among authors: mori t. Acta Med Okayama. 2020 Feb;74(1):89-94. doi: 10.18926/AMO/57959. Acta Med Okayama. 2020. PMID: 32099255 Free article.
Genetic features of B-cell lymphoblastic lymphoma with TCF3-PBX1.
Shirai R, Osumi T, Sato-Otsubo A, Nakabayashi K, Mori T, Yoshida M, Yoshida K, Kohri M, Ishihara T, Yasue S, Imamura T, Endo M, Miyamoto S, Ohki K, Sanada M, Kiyokawa N, Ogawa S, Yoshioka T, Hata K, Takagi M, Kato M. Shirai R, et al. Among authors: mori t. Cancer Rep (Hoboken). 2022 Sep;5(9):e1559. doi: 10.1002/cnr2.1559. Epub 2021 Sep 23. Cancer Rep (Hoboken). 2022. PMID: 34553842 Free PMC article.
Rituximab-combined anthracycline-free chemotherapy in newly diagnosed paediatric and adolescent patients with non-high-risk aggressive mature B cell lymphoma: protocol for a single-arm, open-label, multicentre, phase II study (the Japan Children's Cancer Group Multicentre Trial, JPLSG B-NHL-20).
Sekimizu M, Fukano R, Koga Y, Mitsui T, Fujita N, Mori T, Hori D, Tanaka M, Ohki K, Iwafuchi H, Nakazawa A, Mori T, Kobayashi R, Hashimoto H, M Saito A, Kamei M; Lymphoma Committee of Japan Children’s Cancer Group. Sekimizu M, et al. Among authors: mori t. BMJ Open. 2024 Mar 19;14(3):e080762. doi: 10.1136/bmjopen-2023-080762. BMJ Open. 2024. PMID: 38508620 Free PMC article.
Primary pediatric stage III renal diffuse large B-cell lymphoma.
Hayakawa A, Shimotake N, Kubokawa I, Mitsuda Y, Mori T, Yanai T, Muramaki M, Miyake H, Fujisawa M, Iijima K. Hayakawa A, et al. Among authors: mori t. Am J Case Rep. 2013;14:34-7. doi: 10.12659/AJCR.883775. Epub 2013 Feb 13. Am J Case Rep. 2013. PMID: 23569559 Free PMC article.
9,295 results